...
首页> 外文期刊>Nature reviews Cancer >Novel Drug Delivery System Based on Ginsenoside Rb1 Loaded to Chitosan/Alginate Nanocomposite Films
【24h】

Novel Drug Delivery System Based on Ginsenoside Rb1 Loaded to Chitosan/Alginate Nanocomposite Films

机译:基于人参皂苷RB1的新型药物递送系统加载到壳聚糖/藻酸盐纳米复合膜上

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recently, drug delivery using natural and biodegradable nanoparticles has attracted huge attention. This study focused to deliver an anti-cancer and anti-inflammatory drug Ginsenoside Rb1 through chitosan-Alginate nanocomposite film prepared by solution method. Ginsenoside Rb1 is a dammaran saponin group, which is extracted from an herbaceous plant Panax notoginseng. Ginsenoside loaded alginate-chitosan nanocomposite films were characterized by Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and differential scanning calorimetry (DSC) methods. The FTIR spectra of alginate/chitosan/ginsenoside Rb1 nanocomposite films show that chitosan, alginate, and ginsenoside Rb1 are linked through the hydrogen bonding and dipolar-dipolar interactions. The FESEM image indicates that the chitosan and ginsenoside Rb1 dispersed well in the alginate matrix. The DSC diagrams display that melting temperature of alginate/chitosan/ginsenoside Rb1 nanocomposite films higher than that of chitosan and lower than that of alginate. It means that alginate and chitosan interact together. Investigation of the ginsenoside Rb1 release from alginate/chitosan/ginsenoside Rb1 nanocomposite films at different pH solutions and different ginsenoside Rb1 content has been carried out by ultraviolet-visible spectroscopy method. The rate of drug release is proportional to the increase in pH solution and inversely proportional to the content of loaded ginsenoside Rb1. The Rb1 release process includes two stages: burst release in the first 10 hours, then constant release afterwards. The suitable ratio of alginate/chitosan to prepare the alginate/chitosan/ginsenoside Rb1 nanocomposite films for further investigations was found out to be 8:2. Ginsenoside Rb1 release process from alginate/chitosan/ginsenoside Rb1 nanocomposite films was believed to be first-order kinetics in the first stage, and then the Rb1 release complies with Higuchi kinetic model in the slow release stage. This study demonstrated the novel synthesis methodology to design drug delivery system based on ginsenoside Rb1 loaded to chitosan/alginate nanocomposite films.
机译:近日,采用天然和可生物降解的纳米颗粒药物传递吸引了极大的关注。这项研究的重点通过溶液方法制备的壳聚糖 - 藻酸盐纳米复合膜,提供一种抗癌和抗炎药人参皂甙Rb1。人参皂甙Rb1是dammaran皂苷组,它是从一个草本植物三七提取。人参皂甙海藻酸钠 - 壳聚糖纳米复合膜,其特征在于傅里叶变换红外光谱(FT-IR),扫描电子显微镜(SEM)和差示扫描量热法(DSC)方法。的FTIR光谱的藻酸盐/壳聚糖/人参皂甙Rb1纳米复合薄膜表明,脱乙酰壳多糖,藻酸盐,和人参皂甙Rb1通过氢键和偶极 - 偶极相互作用的联系。的FESEM图像表明,脱乙酰壳多糖和人参皂苷Rb1的藻酸盐基质分散良好。的DSC图表显示藻酸盐/壳聚糖/人参皂甙Rb1的纳米复合膜的该熔融温度比壳聚糖更高且比藻酸盐的降低。这意味着,海藻酸钠和壳聚糖互动起来。从人参皂甙Rb1的释放研究藻酸盐/壳聚糖/人参皂甙Rb1的纳米复合材料在不同pH值的解决方案和不同的人参皂苷Rb1含量的膜已经通过紫外可见分光法的方法进行。药物释放的速率正比于溶液的pH的增加而反比于加载的人参皂苷Rb1的含量。该皂苷Rb1释放过程包括两个阶段:在第一个10小时的突释,然后恒定的释放之后。藻酸盐/壳聚糖的合适的比例以制备藻酸盐/壳聚糖/人参皂甙Rb1的纳米复合材料进一步调查膜被发现是8:2。从藻酸盐/壳聚糖/人参皂甙Rb1纳米复合薄膜人参皂甙Rb1释放过程被认为是在第一阶段的一阶动力学,然后将皂苷Rb1释放符合在缓慢释放阶段樋口动力学模型。本研究证实了新的合成方法,以设计一个基于人参皂甙Rb1的药物递送系统中加载到脱乙酰壳多糖/藻酸盐纳米复合材料薄膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号